Trial intelligence / Profile preview

Vitamin D in Rheumatoid Arthritis

NCT00279461Phase 2Withdrawn

Sponsor
Indiana University
Start
May 2009
Primary completion
May 2011
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Vitamin D Group with Placebo Group (2 arms). Primary endpoint: American College of Rheumatology 20% Improvement Criteria at 6 months. Planned start May 2009; status: withdrawn.

02

Drugs

vitamin d
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT00279461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00279461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call